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Introduction: A mouse model of progeria derived by insertion of the human mutant LMNA gene (mLMNA),
producing mutant lamin A, shows loss of smooth muscle cells in the media of the ascending aorta. We
hypothesized that high shear stress, in the presence of mutant lamin A, induces this vasculopathy and tried to
define the molecular and cellular basis for aortic vasculopathy.
Methods: Ascending and descending aortas from wild type (WT) and mLMNA+ mice were compared using
proteomics, Western blots, PCR and immunostaining. To determine whether high fluidic shear stress, known to
occur in the ascending aorta, contributed to the vasculopathy, we exposed descending aortas of mLMNA+ mice,
with no apparent vasculopathy, to 75 dynes/cm2 shear stress for 30 minutes using a microfluidic system.
Results: When the mice were one year of age, expression of several mechanotransduction proteins in the
ascending aorta, including vimentin, decreased in mLMNA+ mice but no decrease occurred in the descending
aorta. High fluidic shear stress produced a significant reduction in vimentin of mLMNA+ mice but not in similarly
treated WT mice.
Conclusions: The occurrence of mutant lamin A and high shear stress correlate with a reduction in the level of
mechanotransduction proteins in smooth muscle cells of the media. Reduction of these proteins may contribute
over time to development of vasculopathy in the ascending aorta in progeria syndrome.Introduction
Hutchinson-Gilford Progeria Syndrome (HGPS) is an
autosomal dominant genetic disease that involves acceler-
ated aging in children, leading to early death due to myo-
cardial infarction or stroke [1]. Autopsies indicate the
principle phenotypic defect occurs in the media of large
conducting arteries, including the aortas and carotids,
with a loss of smooth muscle cells (SMCs) and extensive
accumulation of extracellular matrix.
Lamin A, a product of the LMNA gene, is a nuclear pro-
tein involved in structural support, DNA replication and
gene transcription through protein-protein interactions
[2-7]. The progeria syndrome occurs as a result of a point
mutation at G608G of the LMNA gene. Substitution of C
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reproduction in any medium, provided the orsite in exon 11 that results in a 50-amino acid deletion
near the C terminus. Consequently, the protein cannot
undergo the final proteolytic processing step in the lamin
A maturation pathway and thus is modified by retention
of a lipid farnesyl group. This mutant form of lamin A,
called progerin, is permanently anchored at the nuclear
envelope [8,9].
An experimental mouse model of progeria was gener-
ated by insertion of the human mutant lamin A gene
(mLMNA) using a bacterial artificial chromosome [9].
As mLMNA+ mice age, loss of SMCs occurs in the
media of the aortas and carotid arteries, with accumula-
tion of matrix proteoglycan [8]. These changes resemble
those reported for the aorta and carotid arteries in HGPS
patients [1,10].
Although the mutant gene product, progerin, is present
in both the ascending and descending aortas in this animal
model, we observed vasculopathy only in the ascending
aortas of 12-month-old mice. Interestingly, the ascendingtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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each cardiac systole [11-13], with the highest shear stress
occurring in the media compared with the intima and
adventitia across the aortic wall [11].
We proposed that progerin in SMCs of the media al-
ters their normal adaptation to high shear stress through
deleterious effects on gene expression and/or protein
conservation. Using wild type (WT) and mLMNA+ mice,
we performed proteomic, molecular, immunohistochem-
ical and fluidic shear stress analyses, and determined
that mechanotransduction proteins, including vinculin,
transgelin and vimentin, all type III intermediate filaments,
may be key proteins that contribute to the vasculopathy
seen in the progeria syndrome.
Materials and methods
Progeria mouse model
A mouse model of HGPS was generated using a bacter-
ial artificial chromosome (BAC) in the laboratory of Dr.
Francis S. Collins [8]. In brief, the BAC was engineered
to carry the single nucleotide mutation at G608G of the
human lamin A gene coding for the dysfunctional pro-
tein, progerin, which is responsible for the progeria syn-
drome in children [8]. All mice were genotyped using
primers 5′-GTGTCTGGGTGCCCTACTCTGGTAAG
GA-3′ and 5′-GTAGGGCAGCAGGCATGCACTATTA-
3′. The investigation conforms to the Guide for the Care
and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication No. 85–23,
revised 1996). All animals were handled following the
guidelines of the Animal Care and Use Committee at the
National Institutes of Health. The animal study protocol
was approved by the Animal Care and Use Committee of
the NIH (Animal Study H-0165) and the approved proto-
col affected all the centers involved in the current study.
Magnetic resonance imaging
Mice were anesthetized with 1 to 2% isoflurane and
imaged with electrocardiography (ECG), respiratory and
temperature detection using a 7.0 T, 160 mm horizontal
Bruker magnetic resonance imaging (MRI) system (Bruker,
Billerica, MA, USA) equipped with a 38 mm birdcage
volume coil. Magnevist (Bayer HealthCare, Montville,
NJ, USA) diluted 1:10 with sterile 0.9% phosphate-
buffered saline, was administered subcutaneously or intra-
venously via tail vein at a dose of 0.3 mmol/L gadolinium/
kg. Two-dimensional multi-slice spin echo images of
the aortas were acquired across the aortic root with
ECG and respiratory gating with the following parame-
ters: TR/TE = 700/10.8 ms, three to four averages, 0.5 to
0.6 mm slice thickness, 2.5 to 2.7 cm field of view,
256 × 256 matrix, resolution approximately 100 × 100 ×
500 μm3. For mice that were also evaluated for left ven-
tricular function, gradient echo cine images were acquiredin short axis from base to apex, with ECG and respiratory
gating. Imaging parameters were TR/TE = 12 to 13/3.2, 30
degree flip angle, 11 to 12 frames, four averages, 1.0 mm
slice thickness, 28 mm field of view, 256 × 256 matrix,
resolution approximately 110 × 110 × 1,000 μm3. Cardiac
MRI data were processed using CAAS-MRV-FARM soft-
ware (Pie Medical Imaging, Maastricht, The Netherlands).
Proteomic analysis
Ascending and descending aortas were homogenized for
10 minutes in protein lysis buffer and a methanol-cleaning
step followed to remove adipose tissues. Protein con-
centrations were determined using the 2-D Quant kit
(GE Healthcare, Piscataway, NJ, USA). Differences were
obtained by gel electrophoresis on triplicate samples.
Specifically, 50 μg of aorta protein from WT and
mLMNA+ mice were labeled with Cy3 and Cy5 dyes
(GE Healthcare). A standard protein solution containing
25 μg of each sample was labeled with Cy2. Labeled
Cy2-, Cy3- and Cy5- samples were loaded on an immo-
bilized pH gradient strip (pH 3 to 10, GE Healthcare).
The first-dimension electrophoresis was run on an Ettan
IPGphor IEF system. Then, the IPG strips were equili-
brated and second-dimension separation was performed
in 10 to 15% gradient gels using an Ettan DALTSix™
electrophoresis (GE Healthcare).
Gels were scanned on a Typhoon 9400 scanner (GE
Healthcare) at 100 μm resolution. The images were proc-
essed with Progenesis Discovery software (Nonlinear
Dynamics, Newcastle, UK). The software quantifies the
ratio of Cy3 WT and Cy5 mLMNA+ spot intensities and
statistical significance was determined by a two-sided
Student’s t-test (n = 3). Spots with greater than a 1.6-fold
change were selected for identification.
The Ettan Spot Handling Workstation was used to ex-
tract the peptides from the gel and transfer the digested
proteins on a matrix-assisted laser desorption/ionization
time of flight mass spectrometry (MALDI-TOF/Pro) (GE
Healthcare). Peptides were analyzed using a 4700 Pro-
teomics Analyzer (Applied Biosystems, Foster City, CA,
USA) tandem MS/MS and proteins were identified with
the MASCOT database search function.
Western blot
Proteins from each sample were applied to a 10% tris-
glycine gel (Invitrogen, Carlsbad, CA, USA) and incu-
bated with primary antibodies overnight at 4°C. Primary
antibodies included rabbit anti-transgelin (1:1,000), mouse
anti-vinculin (1:200), rabbit anti-vimentin (1:500), (Abcam,
Cambridge, MA, USA) and mouse anti-glyceraldehyde
3-phosphate dehydrogenase (GAPDH) (1:5,000, Ambion,
Austin, TX, USA). Secondary antibodies were horse-
radish peroxidase-conjugated goat anti-rabbit or anti-
mouse antibodies (Pierce, Rockford, IL, USA). Enhanced
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Signal® West Femto enhancer kit (Pierce).
Immunohistochemistry and confocal microscopy
Aortas were fixed in 4% formaldehyde solution and
5 μm thick paraffin embedded sections were prepared
(HistoServ, Germantown, MD, USA). After rehydration,
sections were incubated with primary antibody at 4°C
overnight in a moist chamber followed by secondary
antibody incubation for one hour at 37°C. Primary anti-
bodies included mouse anti-smooth muscle α-actin
(ab5694, Abcam), rabbit anti-vimentin (ab45939, Abcam)
and mouse anti-human lamin A/C (Millipore, Palm
Springs, CA, USA). Secondary antibodies included donkey
anti-rabbit, donkey anti-mouse and donkey anti-goat
fluorescein isothiocyanate (FITC) and donkey anti-rabbit
Texas Red® from Jackson Immuno Research (West Grove,
PA, USA). The sections were mounted with Vectashield
containing 4′, 6-diamidino-2-phenylindole (DAPI) to de-
tect cell nuclei. Images were obtained with a confocal
microscope (Leica SP1, Leica Microsystems, Heidelberg,
Germany) and Leica confocal software.
Shear stress experiment
Fluidic shear stress was applied to the ascending and de-
scending aortas of 12-month-old WTand mLMNA+ mice.
A flow system was set up to impose artificial shear stress
on the ascending and descending aortas at 75 dynes/cm2
for 30 minutes by controlling media flow rate. This
matched the highest level observed in the mouse cardio-
vascular system [14]. Wall shear stress (τ) was calculated
using the formula: τ = 4ηQ/πr3, where η is the viscosity of
the media and r is vessel radius. Tubes were connected to
a microfluidic chamber (Harvard Apparatus, Holliston,
MA, USA) and catheters were inserted into the origin of
the ascending aortas. Dulbecco’s Modified Eagle Medium
(Invitrogen) flowed through the ascending and descending
aortas and exited at the vena cava. An additional image file
shows this in more detail (see Additional file 1).
RNA isolation and RT-PCR
To measure vimentin mRNA levels, RT-PCR was per-
formed on the aortas of mLMNA+ mice before and after
shear stress. We carefully removed as much of the adven-
titial layer as possible using a high power dissection micro-
scope, and subsequently harvested the descending aortas.
These consisted mostly of media with a single cell layer of
endothelium. Total RNA was isolated from the descending
aortas using the RNeasy mini kit (Qiagen, Valencia, CA,
USA) and reverse transcriptase-polymerase chain reaction
(RT-PCR) was carried out with a SuperScript kit (Invitro-
gen). The vimentin primer was purchased from Qiagen.
The PCR products were analyzed by agarose gel electro-
phoresis. Beta-actin was used as an internal control.Results
Pathologic phenotypes of mLMNA+ mice
A series of hematoxylin and eosin stained preparations
show changes in the ascending aorta in WT (Figure 1A-C)
and mLMNA+ (Figure 1D-F) mice over a period of 2 to
12 months after birth. In cross-sectional views of the as-
cending aortas at all time-intervals, the endothelial lining
of the intima remains intact as a single layer of endothelial
cells. A thickening of the posterior wall, noted at 2 to
6 months, became prominent at 8 to 12 months in both
WT and mLMNA+ mice. The aorta in WT mice shows a
thickening of the posterior media similar to that seen in
mLMNA+ mice, but there is no apparent loss of SMCs or
change in the adventitial layer. In contrast, the thickened
media of the posterior wall of mLMNA+ mice shows ex-
tensive loss of SMCs at 12 months, with replacement by
extracellular matrix (Figure 1F). An additional difference
was noted at 12 months, the damaged media in mLMNA+
mice is bordered by an expanded adventitia consisting of
fibroblasts, a dense layer of collagen and focal calcification
(Figure 1F). These structural changes in the ascending
aorta of mLMNA+ mice do not occur in the descending
aorta of mLMNA+ mice at this age.
Progerin expression in the ascending and descending
aortas and organs of 12-month-old mLMNA+ mice was
assessed by immunostaining and confocal microscopy.
As expected, all cells were negative for progerin expres-
sion in the aortas (Figure 2A) and other organs in WT
control mice. Surviving SMCs in the media of the ascend-
ing aortas of mLMNA+ mice and in the intact descending
aortas of these mice showed extensive progerin deposition
at the peripheral margin of nuclei (Figure 2B-D). Unex-
pectedly, progerin was not detected in nuclei of endothe-
lial cells in the ascending aortas (Figure 2B) or descending
aortas (Figure 2C, D).
MRI analysis of the lumen of the aortic root
We measured the lumen diameter during diastole at the
root of the ascending aortas in 12-month-old mice using
MRI (Figure 3A-D) and found a significant (P <0.05) re-
duction in mLMNA+ (n = 3) mice (1.33 ± 0.15 mm, n = 7)
compared with WT (n = 3) mice (1.62 ± 0.10 mm, n = 4)
(Figure 3E). Likewise, the average aorta area was reduced
in mLMNA+ mice (Figure 3F). This reduction in the diam-
eter of the lumen and aorta area may lead to an increase
in mechanical stress and thus account for some of the vas-
culopathy observed in the medial wall of the ascending
aortas in mLMNA+ mice.
Protein profiles in WT and mLMNA+ ascending aortas
We tested the hypothesis that progerin modifies gene ex-
pression in the ascending aortas by comparing the protein
profiles of WT and mLMNA+ mice using proteomic ana-
lysis (Figure 4A). Proteins from WT and mLMNA+ mice
Figure 1 Histologic analysis of cross sectional images of the ascending aorta in WT and mLMNA+ mice. In this series of hematoxylin and
eosin stained slides, changes are observed in the ascending aorta in wild type (WT) (A-C) and mLMNA+ (D-F) mice during aging. Prominent
thickening of the media occurs in the posterior wall (P) of WT mice but the media remains intact with a complete layer of smooth muscle cells
(SMCs). In contrast, progressing at 12 months (F), the thickened media in the posterior wall of mLMNA+ mice becomes largely depleted of SMCs
and extensive extracellular matrix is deposited. These damaged areas are bounded by a prominent adventitia that consists of fibroblasts, a dense
layer of collagen and calcification at the boundary of media and adventitia (arrow) (m =months). Scale bar: 250 μm.
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ively. In two-dimensional (2-D) gels, a large number of dif-
ferentially expressed proteins were observed in WT and
mLMNA+ ascending aortas. Using MALDI-TOF analysis,
approximately 26 proteins showed a greater than 1.6-fold
difference between WT and mLMNA+ aortas. Eight pro-
teins were down-regulated in the mLMNA+ ascending
aortas (Figure 4B). Most down-regulated proteins were
cytoskeleton-related or mechanotransduction-related.
Eighteen up-regulated proteins in the mLMNA+ ascend-
ing aortas included many mitochondrial enzymes and
the extracellular matrix protein, collagen VI.
Among the down-regulated proteins, we focused on
those with mechanotransduction properties that mightbe responsive to the high shear stress encountered in the
ascending aortas [15-17]. At 12 months, vinculin, transge-
lin and vimentin were highly expressed in the WT group
as seen by Western blot, whereas levels of expression were
reduced in mLMNA+ mice (Figure 4C). Based on triplicate
samples, vimentin expression, normalized to GAPDH, was
five-fold greater in the ascending aortas of WT mice com-
pared with mLMNA+ mice at 12 months.
Vimentin expression in the intima, media and adventitia
The cellular pattern of vimentin expression in the as-
cending aortas was examined in 12-month-old WT and
mLMNA+ mice by immunostaining and confocal mi-
croscopy. In both groups, the intima was seen as an
Figure 2 Confocal microscopy of progerin expression in 12-month-old WT and mLMNA+ mice. In the ascending aortas in wild type (WT)
mice (A), nuclei of endothelial cells (arrowheads) and smooth muscle cells (SMCs) (arrows), as expected, are negative for progerin expression. In
mLMNA+ mice (B), the endothelial cells (arrowheads) in the ascending aortas are progerin negative, whereas all SMCs (arrows) in the intact
region of the media show progerin deposition in their nuclei, mostly at the peripheral margin. A similar pattern of progerin expression is seen in
the descending segment of the aortas in mLMNA+ mice (C and D); all SMC nuclei (arrows) are progerin positive, but the endothelial cells are
negative (arrowheads). The lumen of each vessel is labeled (L). Blue = DAPI, green = progerin, red = SMαA. Scale bar: 25 μm.
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(Figure 5A,C). Vimentin expression was observed in all
SMCs in the media of the ascending aortas in WT mice
(Figure 5A). Although the surviving SMCs in the aortic
media in mLMNA+ mice were vimentin-positive, exten-
sive depletion of these cells resulted in an overall de-
crease in the level of vimentin (Figure 5C). Thus, visual
comparison of vimentin immunostaining of the ascend-
ing aortas of these two groups of mice, at 12 months,
supported our Western blot findings (Figure 6). To de-
termine the onset of decreased vimentin expression in
mLMNA+ mice, we quantified total vimentin levels
which included all vimentin isomers in the ascending
aortas from 2-, 6- and 12-month-old WT and mLMNA+
mice (Figure 6). Western blot showed no difference at
2 months; however, vimentin in the ascending aortas of
mLMNA+ mice was decreased 30% at 6 months and 60%
at 12 months compared with the WTgroup.
Vimentin was expressed in all endothelial cells of the
ascending aortas in WT and mLMNA+ mice). Further-
more, consistent with Western blot data, immunostainingof descending aortas at 12 months showed a similar pat-
tern of vimentin expression in all three layers in WT and
mLMNA+ mice (Figure 5B,D).Effect of shear stress on gene expression
To test our hypothesis that high shear stress contributes
to the vasculopathy seen in the media of the ascending
aortas of mLMNA+ mice, we applied artificial shear
stress at 75 dynes/cm2 to the descending aortas of WT
and mLMNA+ mice. Western blot analysis (Figure 7A)
of descending aortas following exposure to 30 minutes
of fluidic shear stress showed a 50% lower vimentin level
in mLMNA+ mice compared to the WT group. In an ef-
fort to establish whether the decrease in vimentin in
mLMNA+ mice resulted from a block at the level of gene
transcription, we performed mRNA analysis on descend-
ing aortas from WT and mLMNA+ mice subjected to flu-
idic shear stress and found similar mRNA levels in both
groups (Figure 7B), consistent with post-translational
degradation of vimentin.
Figure 3 MRI of the aorta. Cross sections of the origin of the
ascending aortas seen by spin-echo magnetic resonance imaging
(MRI) in a wild type (A) and an mLMNA + (B) mouse. Images include
the ascending aorta in cross-section, the right atrium and the
pulmonary artery, annotated on image (A). The measured area for
aortic wall thickness and lumen cross sectional area are shown in
the bottom row with two regions of interest (ROIs) indicating the
inner and outer borders of the aortic wall in the wild type (WT)
(C) and mLMNA+ mouse (D). The lumenal cross section is the area
of the inner region of interest (ROI) multiplied by the slice thickness;
the wall area is the area between the two ROI outlines multiplied by
the slice thickness. Lumen diameter (mm) (E) and aorta area (mm2)
(F) of wild type and mLMNA+ mice (n = 3).
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In the mLMNA+ mouse model of progeria, an early indi-
cation of vasculopathy consistently occurred as a thick-
ened zone of the media in the ascending aortas, but not
in the descending aortas, followed by loss of SMCs in
12-month-old mice. Thus, vasculopathy may develop at
a slower rate in the descending aortas where SMCs are
exposed to lower hemodynamic stress compared to the
ascending aortas. This idea is supported by our finding
that when exposed ex vivo to high hemodynamic stress,
the descending aortas in mLMNA+ mice respond with a
decrease in vimentin transcripts and protein compared
with WT mice. Our observation of no vasculopathy in
the descending aortas at this age differs from an earlier
study [9] in which mice were followed for more than
12 months. An explanation for the differences regarding
the extent of vasculopathy seen in these two studies is
the fact that the earlier study [9] utilized mice that had
undergone fewer generational passages [Personal com-
munication, Dr. Francis S. Collins].
Our hypothesis that changes in the media occur in 12-
month-old mice in response to high flow pressure gener-
ating a mechanical force over the wall of the ascending
aortas, is supported by a number of recent papers [11,14].
Phase-contrast MRI and numerical analysis suggest that
local wall stress conditions may be the basis for media
thickening in the wall of the aortic arches [13]. Addition-
ally, simulated computational models of aortas used to
analyze fluid dynamics suggest that hemodynamic stress
encountered in the ascending portion of the aortic arches
is highest at the level of the medial layer [11,12]. Our cal-
culations, based on MRI measurements, indicate that an
18% decrease in lumen diameter occurs at the origin of
the ascending aortas in mLMNA+ mice. This suggests an
80% increase in mechanical stress at this site that is not
encountered in WT mice. Thus, repetitive high stress
associated with each cardiac systole may be a key factor
responsible, over time, for the focal thickening of the
media followed by the loss of SMCs in the ascending
aortas in mLMNA+ mice.
In an effort to define the molecular basis for SMC de-
pletion in the ascending aortas of mLMNA+ mice, we
performed proteomic analyses to identify potential me-
diators of SMC death. Data obtained from protein pro-
files of ascending aortas in WT and mLMNA+ mice, and
confirmed by Western blot and confocal microscopy,
led us to focus on vimentin. This type III intermediate
filament, a component of the cytoskeletal system, is
known to function along with actin and microtubules to
maintain cellular integrity through its role in adhesion,
structure and migration [15]. Other attributes of vimen-
tin include its ability to engage in intracellular signaling
involved in gene expression [16], and vascular remodel-
ing [17,18]. Another attribute that may be relevant to
Figure 4 (See legend on next page.)
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Figure 4 Proteomic analysis and mechanotransduction protein expression of ascending aortas in WT and mLMNA+ mice. (A): Proteomic
analysis of the ascending aortas in wild type (WT) and mLMNA+ mice. This two-dimensional (2-D) gel image shows protein expression in the ascending
aortas of WT (green) and mLMNA+ (red) mice at 12 months. Yellow spots indicate commonly expressed proteins. The image suggests relatively greater
expression of cytoskeleton (myosin regulatory light polypeptide 9, destrin, cytochrome b-c1 complex, actins) and mechanotransduction-related
(vimentin, vinculin, transgelin) proteins in WT relative to mLMNA+ mice, and relatively greater expression in mitochondrial enzymes and extracellular
matrix components in mLMNA+ mice relative to WT mice. A complete list of proteins can be found in (B). (C): Mechanotransduction protein levels in
the ascending aorta of 12-month-old WT and mLMNA+ mice. When vinculin, transgelin and vimentin bands were normalized to glyceraldehyde
3-phosphate dehydrogenase (GAPDH), the quantity of each protein was reduced in LMNA+ mice compared with WT. The level of vimentin was
the most significantly reduced.
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Several cell types [19-21], including vascular SMCs [22],
are reported to undergo apoptosis in response to caspase
cleavage of vimentin, whereas caspase-resistant vimentin
suppresses apoptosis [23]. Defects in mechanotransductionFigure 5 Immunostaining of vimentin in the ascending aortas in W
expression in the ascending aortas in wild type (WT) mice (A and B) w
and confocal microscopy. In WT mice (A) the media of the posterior w
mice (C) the media of the posterior wall is mostly acellular, but the few
cells (arrowheads) are vimentin positive (A and C). Cells of the intima a
mLMNA+ (B) mice were analyzed for vimentin expression. The contiguo
is indicated (arrowheads) as is the SMC layers of the media (arrows). The lum
bar: 25 μm.due to defective SMC vimentin may result in the vasculop-
athy observed in several of the lamin A disorders. Import-
antly, some of the functions attributed to vimentin are
impaired in HGPS patient fibroblasts subjected to repetitive
mechanical strain [24,25].T and mLMNA+ mice at 12 months. The pattern of vimentin
as compared with mLMNA+ mice (C and D) by immunostaining
all is cellular and vimentin positive (arrows), whereas in mLMNA+
surviving SMCs show vimentin staining (arrows). All endothelial
nd media in the descending aortas in 12-month-old WT (A) and
us monolayer of vimentin positive endothelial cells in each vessel
en of each vessel is indicated (L). Blue = DAPI, green = vimentin. Scale
Figure 6 Western blot analysis of vimentin in the ascending
and descending aortas. (A) Vimentin expression was investigated
by Western blot in 2-, 6- and 12-month-old wild type (WT) and
mLMNA+ mice. Blots were performed in triplicate and total vimentin
intensity of the four isomer bands was normalized with glyceraldehyde
3-phosphate dehydrogenase (GAPDH) and the ratio indicated. At two
months, vimentin was expressed at a similar level in WT and mLMNA+
ascending aortas. However, vimentin expression was reduced by 30%
at 6 months and by 60% at 12 months in mLMNA+ ascending aortas.
The 12-month descending aortas showed no difference between WT
and mLMNA+ mice. (B)When the expression bands of SMαA in the
ascending aortas of six-month-old WT and mLMNA+ mice were
normalized to GAPDH, they were similar (ratio = 1.0:0.9). (*P <0.001).
Figure 7 Western blot and mRNA analysis of vimentin in the
descending aortas after artificial shear stress. Vimentin
expression in 12-month-old wild type (WT) and mLMNA+ descending
aortas provided control values for a study that involved a 30-minute
ex vivo exposure to high fluidic shear stress. In triplicate samples no
difference was detected between WT and mLMNA+ control samples
not exposed to shear stress (A). This image was the same figure as
Figure 6A (12 m descending WT and mLMNA+). After exposure to
shear stress, a 50% reduction in vimentin expression was
demonstrated in mLMNA+ mice compared with WT mice (A).
Vimentin mRNA expression in descending aortas of WT and
mLMNA+ mice was obtained by RT-PCR analysis after exposure
to shear stress (B).
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form of lamin A, is involved in the loss of SMCs in the as-
cending aortas of mLMNA+ mice, we utilized immunohis-
tochemistry and confocal microscopy to monitor its
cellular expression. Progerin was detected in all SMCs of
the descending aortas. At sites in the medial layer of the
ascending aortas of 12-month-old mLMNA+ mice where
extracellular matrix replaced the SMCs, the only trace of
progerin occurred in rare, individual surviving SMCs.
Thus the focal reduction in the number of SMCs in the
ascending aortas in mLMNA+ mice formed the basis for
the low level of progerin detected by Western blot.
Endothelial cells of the ascending aortas display a
unique feature in mLMNA+ mice. They form an intact
single cell layer and their survival in the zone of SMC
depletion is characterized by a greater than eight-fold
level of vimentin compared with cells overlying adjacent
regions of media not depleted of SMCs. Implications of
a role for vimentin in survival of endothelial cells are
supported by studies that demonstrate intermediate fila-
ments confer tolerance to high hemodynamic stress
[26,27]. These studies show that vimentin helps endothe-
lial cells to withstand mechanical forces generated by blood
flow and report a greater than two- to three-fold level ofvimentin in endothelial cells of the aortas, where flow-
induced stress is high, compared with the level in endothe-
lium of the vena cava. Furthermore, throughout the aortas
there is an increase in vimentin content in a proximal to
distal direction [27]. In addition to their function in signal
transduction, vimentin filaments in endothelial cells associ-
ate with integrins to form focal contacts and help stabilize
cell-matrix adhesions. These focal contacts are flow-
induced [26]. Data support our view that enhanced
expression of vimentin in endothelial cells over the
zone of vasculopathy helps to maintain cell viability.
Due to their capacity for signal transduction and their
ability to form cell-matrix adhesions that offer resist-
ance to high mechanical stress, endothelial cell sur-
vival is enhanced in the ascending aortas, regions
subjected to high hemodynamic pressure with each
systole. In addition to shear stress, the hoop stress
could also be considered. Hoop stress influences the
vascular wall tension (muscular tension). A simple
computational modeling can give more information
about how hoop stress influences the endothelial and
medial layers of aortas.
A decrease in vimentin, an intermediate filament vital to
cellular survival, in the wall of the ascending aortas was
detected in six-month-old mLMNA+ mice compared with
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cause the loss of vimentin preceded the loss of SMαA or
any evidence for cell death at this age, we speculated that
vimentin loss may contribute to an early stage of the vas-
cular pathology seen in this animal model of HGPS, and
that hemodynamic stresses in the ascending aortas may be
of mechanistic importance in reduced vimentin expres-
sion. To test this concept, we applied mechanical stress to
descending aortas that showed little or no signs of vascu-
lopathy at 12 months of age. After a 30-minute exposure
to hemodynamic forces equivalent to 75 dynes/cm2 there
was a significant reduction in vimentin protein expression
in the descending aortas of mLMNA+ mice compared
with WT mice. We considered vimentin degradation as
an additional mechanism for the rapid decline in vimentin
expression in these 30-minute experiments. Vimentin is a
caspase-3, -6 and -7 substrate that is cleaved at distinct
sites producing multiple fragments [21]. Studies utilizing
single living cells demonstrated a rapid activation of the
caspase cascade leading to apoptosis. Several of these
studies demonstrated activation within 5 to 30 minutes
after exposure to a variety of stimuli. Within 15 minutes
following intestinal epithelial cell detachment, activation
of caspase-6 and cleavage of its substrate - poly (ADP-ri-
bose) polymerase - were detected. This was followed
within 30 minutes by activation of caspase-3 [28]. In an-
other study, using COS-7 cells, activation of caspase-3
was detected five minutes after the initiation event oc-
curred [29]. Similar findings were reported using single
living plant cells. At 30 minutes after exposure to ultravio-
let C, activation of caspase-3 was detected based on a de-
crease in a recombinant fluorescent substrate [30].
Additional studies are required to clarify the potential role
of proteolytic enzymes in degradation of vimentin and
other mechanotransduction filaments during the onset of
vasculopathy in mLMNA+ mice. Furthermore, the poten-
tial role of mitochondrial enzymes up-regulated under
shear stress condition will be studied.
Extracellular matrix (ECM) is connected to cytoskeleton
and could be classified as an ancillary mechanotransduc-
tion protein. In our study, collagen VI expression was sig-
nificantly higher in mLMNA+ ascending aortas compared
to WT aortas. Collagen VI provided a structural link be-
tween ECM and the cell basement membranes. It trans-
lates extracellular mechanical stimuli into intracellular
biochemical signals [26]. They are also involved in
metabolic changes and muscle phenotypes, and lead to
production of altered mechano-sensing, triggering the
onset of diseases.
Conclusions
In conclusion, altered expression of mechanotransduction
proteins in SMCs may contribute to the vasculopathy seen
in the aortas in mLMNA+ mice. Mechanosensitive genesthat participate in the regulation of biochemical pathways
and protein expression were recently identified in aortic
arch endothelial cells. This raises the possibility that these
genes in SMCs may likewise be responsive to altered flow
forces in the presence of the nuclear protein, progerin. A
more complete understanding of possible mechanistic
links involving progerin, vimentin and SMC integrity may
have implications for the treatment of HGPS patients.
Additional file
Additional file 1: Microfluidic system for shear stress experiment.
Tubes were connected to the microfluidic chamber and ascending
aortas, and the media flowed through the tubes.
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